Skip to main content
Log in

Thallium-201 SPECT as response parameter for PCV chemotherapy in recurrent glioma

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Combination chemotherapy with procarbazine, CCNU and vincristine (PCV) may be effective in patients with recurrent glioma. Response monitoring is mandatory, but radiological response evaluation is often difficult. We evaluated Thallium-201 (201Tl) SPECT as a response parameter in ten patients treated with intensive PCV chemotherapy for recurrent glioma. 201Tl-SPECT studies showed early changes (decreasing volume and intensity) in nine patients and these changes were more pronounced than radiological findings. 201Tl-SPECT results after completion of chemotherapy seemed to correlate with clininal findings during follow up. We conclude that 201Tl-SPECT may contribute to the assessment of response in patients treated with PCV chemotherapy for recurrent glioma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Levin VA, Edwards MS, Wright DC, Seager ML, Pischer Schimberg T, Townsend JJ, Wilson CB: Modified procarbazine, CCNU and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumors. Cancer Treat Rep 64: 237–241, 1980

    Google Scholar 

  2. Cairncross JG, Macdonald DR: Successful chemotherapy for recurrent malignant oligodendroglioma. Ann Neurol 23: 360–364, 1988

    Google Scholar 

  3. Macdonald DR, Cascino TL, Schold Jr SC, Cairncross JG: Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8: 1277–1280, 1990

    Google Scholar 

  4. Slizofsky WJ, Krishna L, Katsctos CD, Black P, Miyamoto C, Brown SJ, Vender J, Chevres A, Khan AS, McEvan J, Dadparvar D: Thallium imaging for brain tumors with results measured by a semiquantitative index and correlated with histopathology. Cancer 74: 3190–3197, 1994

    Google Scholar 

  5. Kosuda S, Fujii H, Aoki S, Suzuki K, Tanaka Y, Nakamura O, Shidara N: Reassessment of quantitative thallium-201 brain SPECT for miscellaneous brain tumor. Ann of Nucl Med 4: 257–263, 1993

    Google Scholar 

  6. Mountz JM, Raymund PA, Mckeever PE, Modell JG, Hood TW, Barthel LK, Stafford-Schuck KA: Specific localization of Thallium 201 in human high-grade astrocytoma by microautoradiography. Cancer Res 49: 4053–4056, 1989

    Google Scholar 

  7. Kaplan WD, Takvorian T, Morris JH, Rumbaugh CL, Connoly BT, Atkins HL: Thallium-201 brain tumor imaging: a comparative study with pathologic correlation. J Nucl Med 28: 47–52, 1987

    Google Scholar 

  8. Caircross G, Macdonald D, Ludwin S, Lee D, Cascino T, Buckner J, Fulton D, Dropcho E, Steward D, Schold Jr C, Wainman N, Eisenhauer E: Chemotherapy for anaplastic oligodendroglioma. J Clin Oncol 12: 2013–2021, 1994

    Google Scholar 

  9. Fine HA, Dear KB, Loeffler JS: Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71: 2585–2597, 1993

    Google Scholar 

  10. Mason WP, DeAngelis LM: Procarbazine, CCNU, Vincristine (PCV) chemotherapy (CT) for benign oligodendrogliomas. Neurology 44: 262–263, 1994

    Google Scholar 

  11. Levin VA, Silver P, Hannigan J: Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J Radiat Oncol Biol Phys 18: 321–324, 1990

    Google Scholar 

  12. Doom GC, Hecht S, Brant-Zawadzki M, Berthiaume Y, Norman D, Newton TH: Brain radiation necrosis: MR imaging. Radiology 158: 149–155, 1986

    Google Scholar 

  13. Brada M, Sharpe G: Chemotherapy of high-grade gliomas. Beginning of a new era or the end of the old? Eur J Cancer 32A: 2193–2194, 1997

    Google Scholar 

  14. Black KL, Emerick T, Hoh CK, Hawkins RA, Mazziota J, Becker DP: Thallium-201 SPECT and positron emission tomography equal predictors of glioma grade and recurrence. Neurol Res 16: 93–96, 1994

    Google Scholar 

  15. Lorberboym M, Mandell LR, Mosesson RE, Germano I, Lou W, DaCosta M, Linzer DG, Machac J: The role of Thallium-201 uptake and retention in intracranial tumors after radiotherapy. J Nucl Med 38: 223–226, 1997

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roesdi, M., Postma, T., Hoekstra, O. et al. Thallium-201 SPECT as response parameter for PCV chemotherapy in recurrent glioma. J Neurooncol 40, 251–255 (1998). https://doi.org/10.1023/A:1006090807678

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006090807678

Navigation